Monday, December 9, 2024 at 2-3pm ET                        Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

An overview of the impact and burden of Hepatitis C virus in the US, treatment landscape, elimination progress, access restrictions and the health economics of curative treatment.

This program will review:

• Disease state pathophysiology, burden and impact of untreated Hepatitis C in the US.
• The WHO HCV elimination targets and the progress to date.
• The current treatment landscape and the AASLD/IDSA guideline recommendations for the treatment of HCV.
• The current state of access to HCV treatments and the health economics of curative treatment.

Learning Objectives

• Understand the pathophysiology and organ systems affected by Hepatitis C.
• Recognize the burden and unmet medical needs for patients with HCV.
• Understand the current treatment guidelines for management of patients with HCV.
• Understand the current access of HCV treatments and the health economics of curative treatment.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.